Search

Your search keyword '"Le, Anh T."' showing total 500 results

Search Constraints

Start Over You searched for: Author "Le, Anh T." Remove constraint Author: "Le, Anh T."
500 results on '"Le, Anh T."'

Search Results

1. Direct observation of the Yb(4f13 6s2)F states and accurate determination of the YbF ionization energy

5. Observation and laser spectroscopy of ytterbium monomethoxide, YbOCH$_3$

6. The 1.66 $\mu$m Spectrum of the Ethynyl Radical, CCH

7. Branching ratios, radiative lifetimes and transition dipole moments for YbOH

11. Vietnamese Graduate International Student Repatriates: Reverse Adjustment

12. Analysis of the $\tilde{A}-\tilde{X}$ bands of the Ethynyl Radical near 1.48$\mu$m and Re-evaluation of $\tilde{X}$ State Energies

14. International Female Graduate Students' Experience at a Midwestern University: Sense of Belonging and Identity Development

15. Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non–small Cell Lung Cancer

16. Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

19. Supplementary Figures S1-9 from MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling

22. High resolution electronic spectroscopy of uranium mononitride, UN.

23. The near-infrared spectrum of ethynyl radical

27. MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling

30. The Multi-path Utility Maximization and Multi-path TCP Design

32. Educational Attainment in Australia: A Cohort Analysis. Research Report.

35. ERBB family fusions are recurrent and actionable oncogenic targets across cancer types

37. Supplementary Figure Legends from An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

38. Supplementary Figures 1 - 5 from An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

40. Data from An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

43. Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer

44. Supplementary Figures 1,2, 3 from Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer

45. Supplementary Figures 1-5 from Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non–small Cell Lung Cancer

46. Supplementary Figure 2 from Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer

47. Supplementary Figures 1-5, Tables 1-2 from Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer

50. Supplementary Tables 1-2 from EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases

Catalog

Books, media, physical & digital resources